Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 26.94% Profit

December 02, 2022
ELI LILLY AND COMPANY stock successfully reached the forecast price target as predicted by QuantWave on December 2, 2022. The forecast signal was issued on June 10, 2022, with the stock priced at 289.35 $. The direction of the forecast was long, and the stock reached a price of 367.31 $, resulting in a profit of 26.94%.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The market analysis suggests that potential factors contributing to the stock's movement included positive developments in ELI LILLY AND COMPANY's product pipeline, strong financial performances, and overall industry trends.

QuantWave is an automated forecasting platform that provides users with predictions for various stocks, offering opportunities for potential profits. For those interested in delving deeper into the investment strategy behind QuantWave, QuantSchool offers comprehensive educational resources outlining the key principles for generating consistent income using the forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

DVNDecember 6, 2024DEVON ENERGY CORPORATION Stock Hits QuantWave's Forecast Price Target with 26.9% Profit  ~1 min.

DEVON ENERGY CORPORATION stock successfully reached the price target forecasted by QuantWave on December 6, 2024. The forecast signal was issued on July 18, 2022, with the stock trading at 47.22 $....

METAOctober 27, 2022QuantWave Successfully Achieves 24.83% Profit Target Forecast for Meta Platforms, Inc.  ~2 min.

On October 13, 2022, QuantWave, the automated forecasting platform, issued a short signal for META PLATFORMS, INC. (formerly known as Facebook, Inc.) with a price target of $97.41....

KMIJanuary 21, 2025QuantWave Successfully Achieves 16.15% Profit Target for Kinder Morgan, Inc.  ~1 min.

QuantWave, the automated forecasting platform, recently reached a significant milestone by successfully hitting the price target forecast for Kinder Morgan, Inc....

BACDecember 14, 2023QuantWave Successfully Achieves 10.99% Profit Target Forecast for BANK OF AMERICA CORPORATION Stock  ~1 min.

On December 5, 2023, QuantWave, the leading automated forecasting platform, issued a signal for BANK OF AMERICA CORPORATION stock, predicting a long position with a price of 29.63 $....

CMEMay 2, 2025QuantWave Successfully Hits Price Forecast for CME GROUP INC. with 13.5% Profit  ~1 min.

On February 20, 2025, QuantWave's automated forecasting platform issued a long signal for CME GROUP INC. with a price target of $279.17....